<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE nitf PUBLIC "-//IPTC//NITF DTD 3.0//EN" "nitf-3-0.dtd"><nitf baselang="EN-US"><head><meta content="CITE" name="_lnbillview"/><meta content="00001" name="_lnminrev"/><meta content="May 29, 2017" name="_eoptdate"/><meta content="23:40:50 EDT" name="_eopttime"/><meta content="DOCUMENT_TOKEN_PLACEHOLDER" name="documentToken"/><docdata><doc-id id-string="5NNH-4SG1-F07F-8086" regsrc="lexisnexis.com"/><date.issue norm="20170529T000000Z"/>2017-05-29</docdata><pubdata unit-of-measure="word" item-length="801" name="Euroland"/></head><body><body.head><hedline><hl1>EISAI CO., LTD.&#x200e; : Eisai and Charles River Laboratories Announce Extension of Integrated Drug Discovery Partnership</hl1></hedline></body.head><body.content><block class="link"><a href="http://ct.moreover.com/?a=30733555400&#38;p=2a4&#38;v=1&#38;x=VFS1x4x1JjQQ7edS8FVXaQ">http://ct.moreover.com/?a=30733555400&#38;p=2a4&#38;v=1&#38;x=VFS1x4x1JjQQ7edS8FVXaQ</a></block></body.content></body></nitf>